腮腺恶性肿瘤42年发病与生存趋势
组织学亚型中腺泡细胞癌和鳞状细胞癌APC升高,腺样囊性癌和腺癌NOS的APC下降(P<.05)。黏液表皮样癌、腺癌NOS和鳞状细胞癌的疾病特异性生存显著改善(P<.05)。
要点
- 腮腺恶性肿瘤年龄调整发病率42年间上升58.1%。
- 腺泡细胞癌和鳞状细胞癌APC升高,腺样囊性癌和腺癌NOS下降。
- 黏液表皮样癌、腺癌NOS和鳞状细胞癌疾病特异性生存显著改善。
核心结论
- 自1973年以来腮腺癌发病率持续上升,而头颈部整体癌症发病率下降。
- 需进一步研究腮腺癌病因、危险因素和病理生理以遏制其发病率上升。
研究设计与样本
- 基于SEER人群癌症登记数据库的回顾性分析,查询1973—2015年腮腺恶性肿瘤数据。
- 证据等级为4级。
主要发现
- 腺泡细胞癌APC为1.38,鳞状细胞癌APC为1.58,呈上升趋势。
- 腺样囊性癌APC为-1.63,腺癌NOS APC为-0.86,呈下降趋势(P<.05)。
- 黏液表皮样癌、腺癌NOS和鳞状细胞癌的疾病特异性生存显著改善(P<.05)。
临床怎么用
- 临床需关注腮腺恶性肿瘤发病率上升趋势,尤其是腺泡细胞癌和鳞状细胞癌亚型。
- 对黏液表皮样癌、腺癌NOS和鳞状细胞癌患者,生存改善趋势可参考用于预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a paucity of information regarding the incidence and survival of parotid malignancies over time. METHODS: The Surveillance, Epidemiology, and End Results population-based cancer registry was queried for parotid malignancies from 1973 to 2015. RESULTS: The age-adjusted incidence of parotid malignancies has increased by 58.1% (7.87-12.44 per 1 000 000). Analysis of histologic type revealed an increased annual percent change (APC) of acinar cell carcinoma (1.38) and squamous cell carcinoma (1.58), but decreased APC of adenoid cystic carcinoma (-1.63) and adenocarcinoma NOS (-0.86) (P < .05). The disease-specific survival of mucoepidermoid carcinoma, adenocarcinoma NOS, and squamous cell carcinoma significantly improved (P < .05) over time. CONCLUSION: The incidence of parotid cancer is rising steadily since 1973, while the incidence of overall head and neck cancer has decreased. Further research is necessary to understand the etiology, risk factors, and pathophysiology of parotid cancer to curb its rising incidence. LEVEL OF EVIDENCE: 4.
引用
- Gupta A, Koochakzadeh S, Neskey DM, et al. Incidence and survival trends of parotid malignancies over 42 years. Head Neck. 2020. PMID: 32314846. doi:10.1002/hed.26172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。